Earnings Call
Apr 30, 2026
Q1 FY2026
EPS Estimate
1.55
EPS Actual
—
Post-Earnings Close
$87.11
Earnings Reaction
-9.7%
Clorox's fiscal Q1 2026 results were dominated by a single operational event: the U.S. launch of a new ERP system, which created meaningful demand fulfillment disruptions and obscured the underlying performance of the business. The ERP transition caused out-of-stocks that management estimates cost roughly 3 points of organic sales in the quarter, on top of which there was a favorable 1-point timing shift from early shipments pulled into Q1 from Q2. Stripping out both the ERP-related headwind and that timing benefit, the underlying organic sales decline was approximately negative 1%, broadly consistent with the company's own front-half guidance framework of negative low single digits. The ERP impact also drove more market share loss than anticipated, concentrated in August, with September and October showing sequential improvement as inventories were rebuilt. Fill rates are now described as largely back to normal, with only minor residual issues in the professional channel.
Report generated on Apr 30, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full CLX analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.